| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 14 |
| 1 | ADALIMUMAB | 13 |
| 2 | APREPITANT | 12 |
| 3 | CLOZAPINE | 12 |
| 4 | CARBOPLATIN | 11 |
| 5 | GEMCITABINE HYDROCHLORIDE | 11 |
| 6 | ASPIRIN | 10 |
| 7 | ASPIRIN 325 MG | 10 |
| 8 | ASPIRIN 81 MG | 10 |
| 9 | GEMCITABINE | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TIAGABINE HYDROCHLORIDE | 1 | 0.0119 |
| 1 | GAS RELIEF | 1 | 0.0020 |
| 2 | CHORIONIC GONADOTROPIN | 1 | 0.0018 |
| 3 | XYLOMETAZOLINE HYDROCHLORIDE | 1 | 0.0018 |
| 4 | APREPITANT | 12 | 0.0016 |
| 5 | BUPRENORPHINE HCL | 1 | 0.0011 |
| 6 | IDARUCIZUMAB | 1 | 0.0007 |
| 7 | WHITE PETROLATUM | 1 | 0.0007 |
| 8 | PIMECROLIMUS | 1 | 0.0006 |
| 9 | GLYCERIN SUPPOSITORY | 1 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 12 | 0.0014 |
| 1 | Humanized Monoclonal Antibody Fragment [EPC] | 1 | 0.0007 |
| 2 | Carnitine Analog [EPC] | 1 | 0.0003 |
| 3 | Provitamin D2 Compound [EPC] | 7 | 0.0002 |
| 4 | Nuclear Export Inhibitor [EPC] | 1 | 0.0001 |
| 5 | Leukotriene Receptor Antagonist [EPC] | 3 | 0.0001 |
| 6 | Bile Acid Sequestrant [EPC] | 1 | 0.0001 |
| 7 | PCSK9 Inhibitor [EPC] | 2 | 0.0001 |
| 8 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 14 | 0.0001 |
| 9 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 1 | 0.0001 |